Journal
CIRCULATION RESEARCH
Volume 101, Issue 10, Pages 995-1000Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.107.159228
Keywords
sphingosine; 1-phosphate receptors; smooth muscle cells; neointima
Funding
- NHLBI NIH HHS [HL70850, HL69907, HL70858] Funding Source: Medline
Ask authors/readers for more resources
Neointimal lesion formation was induced in sphingosine 1-phosphate (S1P) receptor 2 (S1P(2))-null and wild-type mice by ligation of the left carotid artery. After 28 days, large neointimal lesions developed in S1P(2)-null but not in wild-type arteries. This was accompanied with a significant increase in both medial and intimal smooth muscle cell (SMC) replication between days 4 to 28, with only minimal replication in wild-type arteries. S1P(2)-null SMCs showed a significant increase in migration when stimulated with S1P alone and together with platelet-derived growth factor, whereas both wild-type and null SMCs migrated equally well to platelet-derived growth factor. S1P increased Rho activation in wild-type but not in S1P(2)-null SMCs, and inhibition of Rho activity promoted S1P-induced SMC migration. Plasma S1P levels were similar and did not change after surgery. These results suggest that activation of S1P(2) normally acts to suppress SMC growth in arteries and that S1P is a regulator of neointimal development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available